A carregar...
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160284/ https://ncbi.nlm.nih.gov/pubmed/32243501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001907 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|